Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Excision BioTherapeutics
Biotech
Moderna hits the gas as it begins dosing of 2nd HIV vaccine
Moderna is diving into human trials head first as it begins dosing in a phase 1 trial for the second of two prophylactic HIV vaccines in development.
Max Bayer
Mar 14, 2022 3:50pm
Moderna, Excision each enter HIV battle with mRNA, CRISPR tech
Jan 27, 2022 11:02am
Excision's HIV CRISPR therapy cleared for human studies by FDA
Sep 17, 2021 10:10am
Fighting COVID-19 and other viruses with gene and cell therapies
Jun 29, 2020 2:15pm
Using CRISPR to eliminate HIV
Jul 3, 2019 10:11am
Moving beyond Cas9, Excision licenses CRISPR gene editors
Nov 13, 2017 10:00am